Journey Medical Corporation (DERM)
NASDAQ: DERM · IEX Real-Time Price · USD
5.24
-0.13 (-2.42%)
At close: Jul 2, 2024, 4:00 PM
5.23
-0.01 (-0.19%)
After-hours: Jul 2, 2024, 5:06 PM EDT

Journey Medical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year
Current20232022202120202019
Market Capitalization
1051073490--
Market Cap Growth
161.97%213.63%-62.07%---
Enterprise Value
99972950105
PE Ratio
--27.67-1.15-2.04--
PS Ratio
1.311.350.461.42--
PB Ratio
8.105.242.002.13--
P/FCF Ratio
89.1020.35-2.51-41.10--
P/OCF Ratio
89.1020.35-2.51-41.10--
EV/Sales Ratio
1.231.220.390.790.220.16
EV/EBITDA Ratio
78.3650.44-1.23-1.511.241.03
EV/EBIT Ratio
-28.63-50.10-1.04-1.401.251.04
EV/FCF Ratio
83.7518.49-2.11-22.741.910.61
Debt / Equity Ratio
1.370.871.570.221.753.74
Debt / EBITDA Ratio
14.129.23-1.15-0.282.271.92
Debt / FCF Ratio
15.103.38-1.97-4.153.521.14
Quick Ratio
0.871.020.901.401.151.14
Current Ratio
1.211.351.161.641.261.21
Asset Turnover
1.151.030.660.851.04-
Interest Coverage
-1.47-1.14-13.64-5.0211.2520.62
Return on Equity (ROE)
-32.80%-34.10%-99.30%-168.10%81.00%-
Return on Assets (ROA)
-6.00%-5.00%-26.50%-59.00%12.30%-
Return on Capital (ROIC)
-8.47%-5.44%-63.11%-68.27%20.45%29.20%
Earnings Yield
-3.97%-3.61%-87.16%-49.08%--
FCF Yield
1.12%4.92%-39.81%-2.43%--
Buyback Yield / Dilution
-10.95%-4.00%-72.05%5.96%-7.55%-
Total Shareholder Return
-10.95%-4.00%-72.05%5.96%-7.55%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).